357 related articles for article (PubMed ID: 24433356)
1. The genomic landscape of retinoblastoma: a review.
Thériault BL; Dimaras H; Gallie BL; Corson TW
Clin Exp Ophthalmol; 2014; 42(1):33-52. PubMed ID: 24433356
[TBL] [Abstract][Full Text] [Related]
2. Genetics and epigenetics of human retinoblastoma.
Benavente CA; Dyer MA
Annu Rev Pathol; 2015; 10():547-62. PubMed ID: 25621664
[TBL] [Abstract][Full Text] [Related]
3. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma.
Corson TW; Gallie BL
Genes Chromosomes Cancer; 2007 Jul; 46(7):617-34. PubMed ID: 17437278
[TBL] [Abstract][Full Text] [Related]
4. Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma.
Grasemann C; Gratias S; Stephan H; Schüler A; Schramm A; Klein-Hitpass L; Rieder H; Schneider S; Kappes F; Eggert A; Lohmann DR
Oncogene; 2005 Sep; 24(42):6441-9. PubMed ID: 16007192
[TBL] [Abstract][Full Text] [Related]
5. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
Pappas L; Xu XL; Abramson DH; Jhanwar SC
Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
[TBL] [Abstract][Full Text] [Related]
6. Genomic landscape of retinoblastoma.
Villegas VM; Gold AS; Wildner A; Ehlies F; Murray TG
Clin Exp Ophthalmol; 2014; 42(1):2-3. PubMed ID: 24433353
[No Abstract] [Full Text] [Related]
7. RB1 gene inactivation by chromothripsis in human retinoblastoma.
McEvoy J; Nagahawatte P; Finkelstein D; Richards-Yutz J; Valentine M; Ma J; Mullighan C; Song G; Chen X; Wilson M; Brennan R; Pounds S; Becksfort J; Huether R; Lu C; Fulton RS; Fulton LL; Hong X; Dooling DJ; Ochoa K; Mardis ER; Wilson RK; Easton J; Zhang J; Downing JR; Ganguly A; Dyer MA
Oncotarget; 2014 Jan; 5(2):438-50. PubMed ID: 24509483
[TBL] [Abstract][Full Text] [Related]
8. High resolution SNP array profiling identifies variability in retinoblastoma genome stability.
Mol BM; Massink MP; van der Hout AH; Dommering CJ; Zaman JM; Bosscha MI; Kors WA; Meijers-Heijboer HE; Kaspers GJ; Riele Ht; Moll AC; Cloos J; Dorsman JC
Genes Chromosomes Cancer; 2014 Jan; 53(1):1-14. PubMed ID: 24249257
[TBL] [Abstract][Full Text] [Related]
9. Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo.
Lambertz I; Nittner D; Mestdagh P; Denecker G; Vandesompele J; Dyer MA; Marine JC
Cell Death Differ; 2010 Apr; 17(4):633-41. PubMed ID: 20019750
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.
Rushlow DE; Mol BM; Kennett JY; Yee S; Pajovic S; Thériault BL; Prigoda-Lee NL; Spencer C; Dimaras H; Corson TW; Pang R; Massey C; Godbout R; Jiang Z; Zacksenhaus E; Paton K; Moll AC; Houdayer C; Raizis A; Halliday W; Lam WL; Boutros PC; Lohmann D; Dorsman JC; Gallie BL
Lancet Oncol; 2013 Apr; 14(4):327-34. PubMed ID: 23498719
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetics and cytology of retinoblastomas.
Bártová E; Kozubek S; Gajová H; Jirsová P; Zlúvová J; Taslerová R; Koutná I; Kozubek M
J Cancer Res Clin Oncol; 2003 Feb; 129(2):89-99. PubMed ID: 12669233
[TBL] [Abstract][Full Text] [Related]
12. Loss at chromosome arm 16q in retinoblastoma: confirmation of the association with diffuse vitreous seeding and refinement of the recurrently deleted region.
Gustmann S; Klein-Hitpass L; Stephan H; Weber S; Bornfeld N; Kaulisch M; Lohmann DR; Dünker N
Genes Chromosomes Cancer; 2011 May; 50(5):327-37. PubMed ID: 21305643
[TBL] [Abstract][Full Text] [Related]
13. Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies.
Rathore S; Verma A; Ratna R; Marwa N; Ghiya Y; Honavar SG; Tiwari A; Das S; Varshney A
Indian J Ophthalmol; 2023 Jul; 71(7):2662-2676. PubMed ID: 37417104
[TBL] [Abstract][Full Text] [Related]
14. Molecular karyotype of sporadic unilateral retinoblastoma tumors.
Ganguly A; Nichols KE; Grant G; Rappaport E; Shields C
Retina; 2009; 29(7):1002-12. PubMed ID: 19491728
[TBL] [Abstract][Full Text] [Related]
15. Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications.
Lee C; Kim JK
J Cell Physiol; 2021 Apr; 236(4):2318-2332. PubMed ID: 32840881
[TBL] [Abstract][Full Text] [Related]
16. MiR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2.
Lei Q; Shen F; Wu J; Zhang W; Wang J; Zhang L
Oncol Rep; 2014 Jul; 32(1):261-9. PubMed ID: 24807198
[TBL] [Abstract][Full Text] [Related]
17. Regulation of p14ARF expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma development.
To KH; Pajovic S; Gallie BL; Thériault BL
BMC Cancer; 2012 Feb; 12():69. PubMed ID: 22336108
[TBL] [Abstract][Full Text] [Related]
18. Constitutional genomic instability, chromosome aberrations in tumor cells and retinoblastoma.
Amare Kadam PS; Ghule P; Jose J; Bamne M; Kurkure P; Banavali S; Sarin R; Advani S
Cancer Genet Cytogenet; 2004 Apr; 150(1):33-43. PubMed ID: 15041221
[TBL] [Abstract][Full Text] [Related]
19. Genomic differences between retinoma and retinoblastoma.
Sampieri K; Mencarelli MA; Epistolato MC; Toti P; Lazzi S; Bruttini M; De Francesco S; Longo I; Meloni I; Mari F; Acquaviva A; Hadjistilianou T; Renieri A; Ariani F
Acta Oncol; 2008; 47(8):1483-92. PubMed ID: 18785023
[TBL] [Abstract][Full Text] [Related]
20. Differentially expressed miRNAs in retinoblastoma.
Martin J; Bryar P; Mets M; Weinstein J; Jones A; Martin A; Vanin EF; Scholtens D; Costa FF; Soares MB; Laurie NA
Gene; 2013 Jan; 512(2):294-9. PubMed ID: 23103829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
